Environmental exposures and women's health

Clinical Obstetrics and Gynecology

Volumn 45, Issue 4, 2002, Pages 1119-1128

  Silbergeld, Ellen K ^a   Flaws, Jodi A ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 2 PYRROLIDINONE; 4,4' ISOPROPYLIDENEDIPHENOL; ALKYLPHENOL; CADMIUM; DICHLORVOS; DIMPYLATE; LEAD; MERCURY; PHTHALIC ACID;

AMBIENT AIR; AUTOIMMUNE DISEASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; HEALTH; HUMAN; OSTEOPOROSIS; POLLUTANT; REVIEW; SEX DIFFERENCE;

ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; WOMEN'S HEALTH;

EID: 0036893164     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200212000-00019     Document Type: Review

References (58)

1. Moss NE. Socioeconomic inequalities in women's health. In: Goldman MB, Hatch MC, eds. Women's Health. San Diego: Academic Press, 2000:541-52.
2. Brown P. Race, class and environmental health. Environ Res. 1995;69:15-30.
3. Zanobetti A, Schwartz J. Race, gender, and social status as modifiers of the effects of PM10 on mortality. J Occup Environ Med. 2000;42:469-74.
4. Johanning E, Landsbergis P, Gareis M, et al. Clinical experience and results of a Sentinel Health Investigation related to indoor fungal exposure. Environ Health Perspect. 1999;107:489-94.
5. Schettler, Solomon, Valenti M, Huddle A. Generations at Risk. Cambridge: MIT Press, 1999.
6. Rudel RA, Brody JG, Spengler JD, et al. Identification of selected hormonally active agents and animal mammary carcinogens in commercial and residential air and dust samples. JAWMA. 2001;51:499-513.
7. Levin RB, Epstein PR, Ford TE, et al. U.S. drinking water challenges in the twenty-first century. Environ Health Perspect. 2002;110:43-52.
8. Sosniak WA, Kaye WE, Gomez TM. Data linkage to explore the risk of low birth-weight associated with maternal proximity to hazardous waste sites from the NPL. Arch Environ Health. 1994;49:251-5.
9. Velema JP, Ferrera A, Figueroa M, et al. Burning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in Honduras. Int J Cancer. 2002;97:536-41.
10. Carruth AK, Gilbert K, Lewis B. Environmental health hazards: The impact on a southern community. Public Health Nurs. 1997;14:259-67.
11. McCann M. Health and safety programs for art and theater schools. Occup Med. 2001;16:659-77.
12. Dorevitch S, Babin A. Health hazards of ceramic artists. Occup Med. 2001;16:563-75.
13. Burger J. Gender differences in attitudes about fish safety in a coastal population. J Toxicol Environ Health. 1998;53:181-92.
14. Centers for Disease Control. National Report on Human Exposure to Environmental Chemicals. Atlanta: NCEH; Pub No 01-0164, 2001.
15. Magee CA, Loffredo CA, Correa-Villasenor A, Wilson PD. Environmental factors in occupations, home and hobbies. In: Ferencz C, Rubin JD, Loffredo A, Magee CA, eds. Epidemiology of Congenital Heart Disease. Mt. Kisco, NY: Futura, 1993:207-32.
16. Roberts JS, Silbergeld EK. Pregnancy, lactation and menopause: How physiology and gender affect the toxicity of chemicals. Mt Sinai J Med. 1995;62:343-55.
17. Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect. 1993;101:378-84.
18. DeBruin LS, Josephy PD. Perspectives on the chemical etiology of breast cancer. Environ Health Perspect. 2002;110:119-28.
19. Craan AG, Haines DA. Twenty-five years of surveillance for contaminants in human breast milk. Arch Environ Contam Toxicol. 1998;35:702-10.
20. Hooper K, McDonald TA. The PBDEs: An emerging environmental challenge and another reason for breast-milk monitoring programs. Environ Health Perspect. 2000;108:387-92.
21. Bjorkman L, Vahter M, Pedersen NL. Both the environment and genes are important for concentrations of cadmium and lead in blood. Environ Health Perspect. 2000;108:719-22.
22. McTernan PG, Anderson LA, Anwar AJ, et al. Glucocorticoid regulation of p450 aromatase activity in human adipose tissue: Gender and site differences. J Clin Endocrinol Metab. 2002;87:1327-36.
23. Seeman E. Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab. 2001;86:4576-84.
24. Gulson BL, Pounds JG, Mushak P, et al. Estimation of cumulative lead releases (lead flux) from the maternal skeleton during pregnancy and lactation. J Lab Clin Med. 1999;134:631-40.
25. Silbergeld EK, Schwartz J, Mahaffey K. Lead and osteoporosis: Mobilization of lead from bone in postmenopausal women. Environ Res. 1988;47:79-94.
26. Giusti RM, Iwamoto K, Hatch EE. Diethyl-stilbestrol revisited: A review of the longterm health effects. Ann Intern Med. 1995;122:778-88.
27. Toppiari J, Skakkebaek NE. Sexual differentiation and environmental endocrine disrupters. Baillieres Clin Endocrinol Metab. 1998;12:143-56.
28. Silbergeld EK, Flaws JA, Brown KM. Organizational and activational effects of estrogenic endocrine disrupting chemicals. Cad Saude Publica. 2002;18:495-504.
29. Rier SE, Martin DC, Bowman RE, Becker JL. Immunoresponsiveness in endometriosis: Implications of estrogenic toxicants. Environ Health Perspect. 1995;103:151-6.
30. Flaws JA, Hirshfield AN. Reproductive, developmental, and endocrine toxicology: Comprehensive toxicology. In: Boekelheide K, Chapin RE, Hoyer PB, Harris C, eds. Reproductive and Endocrine Toxicology. Volume 10. Cambridge: Cambridge University Press, 1997:283-91.
31. Halbreich U. Menstrually related disorders: What we do know, what we only believe that we know, and what we know that we do not know. Crit Rev Neurobiol. 1995;9:163-75.
32. Keye WR Jr. Environmental exposure and altered menstrual function. Prog Clin Biol Res. 1984;160:203-9.
33. Cohn PD, Fagliano JA, Klotz JB. Assessing human health effects from chemical contaminants in drinking water. N Engl J Med. 1994;91:719-22.
34. Savitz DA, Andrews KW, Pastore LM. Drinking water and pregnancy outcome in central North Carolina: Source, amount, and trihalomethane levels. Environ Health Perspect. 1995;103:592-6.
35. Hertz-Picciotto I, Swan SH, Neutra RR, Samuels SJ. Spontaneous abortions in relation to consumption of tap water: An application of methods from survival analysis to a pregnancy follow-up study. Am J Epidemiol. 1989;130:79-93.
36. Wrensch M, Swan SH, Lipscomb J, et al. Spontaneous abortions and birth defects to tap and bottled water use, San Jose, California, 1980-1985. Epidemiology. 1992;3:98-103.
37. Solomon GM, Morse EP, Garbo MJ, Milton DK. Stillbirth after occupational exposure to N-methyl-2-pyrrolidone. A case report and review of the literature. J Occup Environ Med. 1996;38:705-13.
38. Romero P, Barnett PG, Midtling JE. Congenital anomalies associated with maternal exposure to oxydemeton-methyl. Environ Res. 1989;50:256-61.
39. Sowers M, LaPietra MT. Menopause: Its epidemiology and potential association with chronic diseases. Epidemiol Rev. 1996;17:287-302.
40. Wood JW. Dynamics of Human Reproduction: Biology, Biometry, Demography. New York: Aldine de Gruyter, 1994.
41. Everson RB, Sandler DP, Wilcox AJ, et al. Effect of passive exposure to smoking on age at natural menopause. Br Med J. 1986;293:792.
42. Staropoli C, Flaws J, Bush T, Moulton A. Cigarette smoking and frequency of menopausal hot flashes [abstract]. Am J Epidemiol. 1997;145:S18.
43. Pieleszek A. The effect of carbon disulphide on menopause, concentration of monoamines, gonadotropins, estrogens and androgens in women. Ann Acad Med Stetin. 1997;43:255-67.
44. Lahita RG. The connective tissue diseases and the overall influence of gender. Int J Fertil. 1996;41:156-65.
45. Rider V, Abdou NI. Gender differences in autoimmunity: Molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol. 2001;1:1009-24.
46. Grossman CJ, Roselle GA, Mendenhall CL. Sex steroid regulation of autoimmunity. J Steroid Biochem Mol Biol. 1991;40:649-59.
47. Van G, Schoenfeld D, Penney C, et al. Identification of premature ovarian failure patients with underlying autoimmunity. J Womens Health Gen Based Med. 2000;9:275-87.
48. Gebbers JO. The environment and autoimmunity, from external causes to inner conflicts. Schweiz Rundsch Med Prax. 2001;90:1913-22.
49. Stafford EA, Rose NR. Newer insights into the pathogenesis of experimental autoimmune thyroiditis. Int Rev Immunol. 2000;19:501-33.
50. Pollard KM, Pearson DL, Hultman P, et al. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity. Environ Health Perspect. 1999;107:729-35.
51. Silbergeld EK, Silva I, Nguyen P, et al. Interactions between mercury and experimental autoimmune disease. Autoimmun Rev. 2002;1:5.
52. Jenis LG, Waud CE, Stein GS, et al. Effect of gallium nitrate in vitro and in normal rats. J Cell Biochem. 1993;52:330-6.
53. Bhattacharyya MH, Jeffery E, Silbergeld EK. Bone metabolism: Effects of essential and toxic trace metals. In: Chang L, ed. Toxicology of Metals. Boca Raton, FL: CRC Press, 1996:959-71.
54. Ergun C, Webster J, Bizios R, Doremus RH. Hydroxylapatite with substituted magnesium, zinc, cadmium, and yttrium. I. Structure and microstructure. J Biomed Mater Res. 2002;59:305-11.
55. Tsuritani I, Honda R, Ishizaki M, et al. Impairment of vitamin D metabolism due to environmental cadmium exposure, and possible relevance to sex-related differences in vulnerability to bone damage. J Toxicol Environ Health. 1992;37:519-33.
56. Silbergeld EK, Sauk J, Somerman M, et al. Lead in bone: Storage site, exposure source, and target organ. Neurotoxicology. 1993;14:225-36.
57. Puzas JE, Sickel MJ, Felter ME. Osteoblasts and chondrocytes are important target cells for the toxic effects of lead. Neurotoxicology. 1992;13:783-8.
58. Nash E, Silbergeld E, Magder L, Stolley P. Menopause, hormone replacement therapy (HRT), and blood lead levels among adult women from NHANES III, 1988-1994. Am J Epidemiol. 1998;147:S93.